Best Shoes for Cuboid Syndrome
Cuboid-syndrome footwear evidence: published stiffness and insole figures, individual pad-fit questions, assessment and case-report limits.
On this page
Spec analysis — not yet tested · Published September 2026
No original shoe measurements or wear-test records are documented here. The tables credit manufacturer information or RunRepeat laboratory samples, and no shoe carries a score or Seal. The cited cuboid reviews describe limited clinical-report evidence for clinician-directed care; they do not establish a retail-shoe treatment winner. Testing-method disclosure →
Correction (9 October 2026): Corrected sample-prevalence inferences, guaranteed pad-clearance arithmetic, arch-based prescriptions and conflicting source counts. Published sample figures and buying targets remain; the cited clinical reviews do not establish a retail-shoe treatment winner or guaranteed recurrence prevention.
Cuboid syndrome is one possible explanation for outer-midfoot pain. The cited reviews describe an uncertain mechanism and no definitive confirmatory test, so an examination and other possible causes matter. They discuss manipulation and external supports, but do not prove quick relief or that shoe features prevent recurrence. This page compares published footwear information within those limits.
Published torsional-rigidity and liner figures are construction comparisons, not proof of a cuboid-syndrome treatment. The cited review discusses individualized padding; it does not establish that every reader needs a pad or a particular retail-shoe stiffness.
Where the cuboid is, and what “syndrome” is doing in the name
The cuboid is a small block of bone on the outside of the midfoot, between the heel bone behind it and the fourth and fifth metatarsals in front. The joint it makes with the calcaneus — the calcaneocuboid joint — is the outer half of the midtarsal joint, and it carries load through the middle of the step while the peroneus longus tendon runs in a groove underneath it and turns the corner towards the arch.
The word “syndrome” is doing real work in the name. A 2011 review in Sports Health collecting everything published on the condition concluded that it is thought to arise from a subtle disruption of the arthrokinematics or structural congruity of that joint, and that the precise mechanism has not been established. There is a candidate: a fibroadipose fold of tissue — a labrum — sits inside the calcaneocuboid joint, and in a cadaveric study of 41 feet it occupied about 35% of the joint space, more than any other joint in the foot. If that fold gets caught, a manipulation that frees it would explain the audible click people describe. The review’s own word for this explanation is “highly speculative”, and we are not going to upgrade it.
| Where and when it hurts | Often described as | Where to read next |
|---|---|---|
| Outer midfoot, deep, worse on push-off and on uneven ground; often started with an inversion sprain | Cuboid syndrome | This page |
| Behind and below the outer ankle bone, tender along a cord you can trace upward | Peroneal tendinopathy | Shoes for peroneal tendonitis |
| A soft dimple just in front of the outer ankle bone, worse standing on one leg on uneven ground | Sinus tarsi syndrome | Shoes for sinus tarsi syndrome |
| A point on the bone at the base of the fifth toe’s long bone, worse with every step, no better after a week | Fifth metatarsal stress injury | Shoes for stress fractures — and be seen |
| A visible lump on the outer edge at the ball of the foot that only hurts in certain shoes | Bunionette | Shoes for a tailor’s bunion |
An orientation table, not a diagnosis — and the first row is the one with no confirmatory test, which is exactly why the others are listed beside it. Persistent bone-point pain on the outer foot is a reason to be examined, not a reason to shop. See our editorial policy.
What the literature actually says
The most useful single source is Durall’s 2011 review in Sports Health, which searched the literature for every term the condition has been given — subluxed, locked, dropped, cuboid fault — and reported what it found, including the parts that were missing. It is open access, and it is refreshingly blunt.
- Reported proportions are sample-specific. Durall’s review reports about 4 percent of 3,600 athletes assessed for foot injuries, 17 percent of ballet dancers with foot/ankle injuries and 6.7 percent of a post-sprain sample. The review says prevalence is unclear; these proportions do not establish the rate in the general population or which injury most often preceded all cases.
- Diagnostic limits in the cited 2011 review. Durall reported no definitive confirmatory test at that time and described a clinical diagnosis using signs and examination. This dated review is not a comprehensive current inventory of diagnostic evidence.
- Foot type does not prescribe a shoe. The review reports pronated feet in 80 percent of one series and also describes cuboid syndrome in high-arched feet. Neither observation establishes a required stability category, width or benefit from a named retail model.
- Footwear is mentioned in the cited review. Ill-fitting or poorly constructed shoes/orthoses appear among possible contributing factors. That does not prove a particular shoe prevents or treats the condition, nor establish that footwear appears only once in all evidence.
- Clinician-directed care. The review discusses manipulation unless contraindicated, plus taping, orthoses or padding in follow-up. These are limited clinical-report recommendations, not a mandatory sequence or a proven recurrence-prevention result. Do not attempt manipulation from a buying guide.
- Guideline limits in the cited 2011 review. Durall described a lack of evidence-based guidelines and relied on the available clinical reports and reasoning. Those statements describe that review’s evidence base, not every study published since.
Source: Durall CJ. Examination and Treatment of Cuboid Syndrome: A Literature Review. Sports Health 2011;3(6):514–519. Open access.
Published torsional-rigidity figures and their limits
Torsional rigidity is resistance to twisting, measured in newton-metres in the listed lab tests. It is a construction comparison. The proposed joint mechanism does not prove that a stiffer shoe reduces joint demand, treats pain or prevents recurrence in cuboid syndrome.
The dated source dataset used for this table contains 24 torsional-rigidity readings, all attributed to RunRepeat. No manufacturer value was recorded in those checked entries. This is not an exhaustive statement about every regional product page or later publication.
| Shoe | Torsional rigidity | Other stiffness figures | Who published it |
|---|---|---|---|
| Brooks Glycerin 23 | 14.0 Nm | Longitudinal 15.2 N (lab average 15.5) · heel counter 4/5 | RunRepeat lab |
| Brooks Ghost 18 | 12.2 Nm | Forefoot flexibility 12.3 N · heel counter 5/5 | RunRepeat lab |
| The other 22 shoes the lab has twisted | 10.3 to 20.5 Nm; median of all 24, 14.5 | Forefoot flexibility 10.9 to 23.1 N · heel counter 2/5 to 5/5 | RunRepeat lab |
| Other entries in the dated dataset | No figure | Forefoot flexibility and heel counter on 11 dated RunRepeat entries; other values not recorded | No source recorded in these entries |
Read September 2026; the two named figures are also cited on each shoe’s own page here. Higher is stiffer. Twenty-four readings are a scale, and on it the Glycerin 23 sits 14th and the Ghost 18 19th, both below the median of 14.5 Nm. The dated dataset and its recorded publishers are listed in the shoe spec database.
What the fuller data shows is a wide spread. Of the 24 shoes we review that the lab has twisted, the stiffest are the ASICS Gel-Nimbus 28 at 20.5 Nm, the ASICS Gel-Kayano 32 at 20.2 and the HOKA Arahi 8 at 19.5, and the least resistant is the New Balance 1080v15 at 10.3. The Adrenaline GTS 25, the third shoe picked below, measured 14.3 and sits 13th, so all three picks fall under the median. The chart of all 24 shows where each one sits.
A missing value limits a numerical stiffness comparison. Even a published torsional-rigidity number does not establish clinical midfoot control or a treatment ranking for cuboid syndrome. The figures below should be read as attributed sample specifications.
Padding range and actual shoe fit
The cited review describes felt padding about 3–6 mm thick under the medial aspect of the cuboid, with individualized position and dimensions; it also discusses a lateral heel wedge. These descriptions are for clinician-directed fitting, not a self-placement prescription or a guaranteed way to stop bone movement.
Insole thickness and removability can help plan a fitting check, but they do not measure usable volume where a localized pad sits. Removing a 5 mm liner does not prove room for a 5 mm pad or adequate foot/heel security. Check the actual device and shoe together.
| Shoe | Insole thickness | Removable? | What that leaves for a 3–6 mm pad |
|---|---|---|---|
| Brooks Ghost 18 | 5.0 mm | Yes, per Brooks | 5.0 mm liner figure; does not guarantee pad clearance |
| Brooks Adrenaline GTS 25 | 4.9 mm | Yes, per Brooks | 4.9 mm liner figure; actual pad clearance unmeasured |
| Brooks Glycerin 23 | 4.4 mm | Yes | 4.4 mm liner figure; actual pad clearance unmeasured |
| The other 32 shoes the lab has measured | 3.5 to 6.6 mm; median of all 35, 4.9 | Usually stated by the brand | Published liner thicknesses; no sample-wide pad-fit guarantee |
| Other entries in the dated dataset | Not recorded in checked sources | Removability/thickness not recorded in these checked entries | Check the actual shoe/device fit |
Insole thicknesses measured by RunRepeat’s laboratory; removability as published by Brooks. ⚠️ The three named rows are all Brooks because they are the three shoes picked below — not because Brooks is the only brand the lab has cut open: its 35 insole readings cover nine brands. One exception worth knowing: Orthofeet states company-wide that its shoes are built with extra depth and ship with removable orthotic insoles a quarter of an inch thick, which is 6.35 mm — the top of the pad’s range in a shoe designed to be emptied.
The device-fit discussion describes practical clearance checks, not a validated one-minute test or a completed product rating. A localized pad and a full-length device may occupy space differently, so try the actual prescribed setup.
The shoes whose published figures fit the brief
These three examples have attributed stiffness and insert figures. They have not been tested by this site and have no score. Neither figure establishes a proven cuboid-treatment shortlist; the cards describe specifications and fitting questions.
Both stiffness numbers, and the top heel-counter grade
Brooks Ghost 18 Spec analysis
The dated RunRepeat data lists Ghost 18 at 12.2 Nm torsional rigidity, 12.3 N forefoot flexibility and 5/5 heel-counter stiffness, a grade shared by six other samples. The liner is listed at 5.0 mm and Brooks says it is removable. Narrow-to-X-Wide options are fitting choices; neither pronation nor liner thickness proves width requirements or room for a 3–6 mm pad.
No Brooks stack value was recorded in the checked dated sources for Ghost 18. The table preserves the stated 10 mm drop and RunRepeat sample 12.2 mm drop (37.3 mm heel, 25.1 mm forefoot). Its 12.2 Nm torsional reading is 19th of the 24 samples in the table, below the 14.5 Nm median. These rankings describe the dataset, not clinical suitability.
| Published figure | Value |
|---|---|
| Torsional rigidity | 12.2 Nm RunRepeat lab |
| Forefoot flexibility | 12.3 N to bend RunRepeat lab |
| Heel-counter stiffness | 5 / 5 RunRepeat lab |
| Insole | 5.0 mm, removable RunRepeat lab · Brooks |
| Heel-to-toe drop | 10 mm Brooks |
| Stack heights | Not recorded in checked dated Brooks sources — |
| Weight, men’s | 289.2 g, size not stated Brooks |
| Widths | Narrow, Normal, Wide, X-Wide Brooks |
| List price | $150 Brooks |
Soft underfoot, mid-table in torsion
Brooks Glycerin 23 Spec analysis
At 14.0 Nm it resists twist harder than the Ghost 18, though it ranks only 14th of the 24 shoes we review that the lab has twisted, and its longitudinal stiffness of 15.2 N sits essentially on the laboratory’s own average of 15.5 — a shoe that is ordinary front-to-back and close to ordinary side-to-side. Its 4.4 mm removable insole is the thinnest of the three picks here, and its midsole measured 29.2 on the Asker C scale against a laboratory average of 35.6, so the pad is going into a soft shoe rather than a hard one.
The listed men’s width options are D and 2E, the liner is 4.4 mm and the dated price is $175. Check whether an available size/width fits the individual foot and device. The 80 percent pronation figure does not establish required width or prove that this range is inadequate for the diagnosis.
| Published figure | Value |
|---|---|
| Torsional rigidity | 14.0 Nm RunRepeat lab |
| Longitudinal stiffness | 15.2 N (lab average 15.5) RunRepeat lab |
| Heel-counter stiffness | 4 / 5 RunRepeat lab |
| Insole | 4.4 mm, removable RunRepeat lab |
| Midsole softness | 29.2 AC (lab average 35.6) RunRepeat lab |
| Heel stack · forefoot stack | 37.2 mm · 29.0 mm RunRepeat lab |
| Heel-to-toe drop | 8 mm stated · 8.2 mm measured Brooks · RunRepeat lab |
| Widths | M: D/2E Brooks |
| List price | $175 Brooks |
Published stability construction; individual fit still matters
Brooks Adrenaline GTS 25 Spec analysis
Adrenaline GTS 25 is listed as a stability design with a 4.9 mm removable liner, 4/5 heel-counter stiffness, 14.3 N longitudinal stiffness, 14.3 Nm torsional rigidity and Narrow-to-X-Wide fittings. The review’s pronated-foot series does not prove that this construction treats cuboid syndrome or is required by an arch shape.
Its 14.3 Nm torsional result is 13th of the 24 dated samples, below the 14.5 Nm median. The cited review also reports cuboid syndrome in high-arched feet; neither arch shape automatically proves this model helpful or harmful. Compare individual fit and any clinical plan.
| Published figure | Value |
|---|---|
| Torsional rigidity | 14.3 Nm RunRepeat lab |
| Longitudinal stiffness | 14.3 N RunRepeat lab |
| Heel-counter stiffness | 4 / 5 RunRepeat lab |
| Insole | 4.9 mm, removable RunRepeat lab · Brooks |
| Midsole softness | 34.5 AC, down from 44.1 on the GTS 24 RunRepeat lab |
| Heel stack | 36.1 mm RunRepeat lab |
| Heel-to-toe drop | 10 mm stated · 10.2 mm measured Brooks · RunRepeat lab |
| Widths | Narrow, Normal, Wide, X-Wide Brooks |
| List price | $155 Brooks |
Fit questions for other shoe designs
Skechers Hands Free Slip-ins is a family of designs, not a single model. Check the exact model’s published features, adjustment, liner removability and actual device fit. The earlier checked entries did not record certain specifications; that absence does not establish that every slip-in model is unmodifiable or a wrong instrument for this diagnosis.
Slides and backless clogs differ in heel retention and device-fitting options. The OOFOS OOahh discussion describes one example, but this page does not prove every such design unsuitable or that no pad can be positioned in any of them. Use the individual clinical/fitting requirements rather than a category ban.
What the research actually supports — and where it stops
The clinical discussion here uses Durall (2011) and Patterson (2006). These reviews describe limited clinical reports and uncertain diagnostic/treatment evidence. This page has not performed a comprehensive current search proving that nothing stronger has ever been published. The shoe tables themselves are specification comparisons, not treatment trials.
Durall describes a clinical diagnosis without definitive confirmatory tests and a lack of evidence-based guidelines. Patterson also discusses clinician-directed manipulation and adjunct supports from the available reports. Favourable case reports do not establish a guaranteed response, comparison against alternatives or a mandatory treatment sequence.
Persistent outer-midfoot pain needs an assessment rather than diagnosis by shoe choice. A clinician can consider other causes and whether any manipulation or external support is appropriate. Do not attempt the technique from a video. The cited reports do not establish shoes or pads as a proven third-step recurrence-prevention treatment.
Where to buy
Disclosure: the links below are paid links. If you buy through them Amazon pays us a commission at no cost to you. Commission rates differ between products; we do not rank by commission rate, and nothing on this page is scored because none of these shoes has been tested by us — see our independence policy.
These two buying targets correspond to the examples listed below. The earlier only-two-figures explanation conflicts with the 24-sample table above and has been removed. Prices change; check the exact model and listing. Neither shoe is scored or established as a treatment winner.
Questions people ask
Can I do the cuboid manipulation myself?
Do not attempt manipulation from a buying guide or video. The cited reviews discuss clinician-directed techniques only after assessment and consideration of contraindications. Your activity restrictions and follow-up should come from the treating clinician; the page cannot prescribe a universal post-manipulation timetable.
Is it worse in a soft shoe or a stiff one?
This page has no clinical comparison proving soft or stiff footwear better for cuboid syndrome. Softness and torsional resistance are different tests: the dated Glycerin 23 sample is 29.2 Asker C and 14.0 Nm; New Balance 860v15 is 25.8 and 18.2 Nm. Those figures describe samples, not pain relief or a required construction.
Will an over-the-counter insole do instead of a pad?
The reviews discuss both orthoses and individualized padding, but do not prove them interchangeable or prescribe one for every person. Check the intended clinical purpose and actual shoe fit rather than choosing from thickness alone. The insoles hub describes related published evidence.
I sprained my ankle two months ago and the outer midfoot still hurts. Is this it?
It is one possibility, but persistent pain after a sprain needs assessment for other causes too. The cited 6.7 percent belongs to a post-sprain sample, not your diagnostic probability. A peroneal-tendon problem, bone injury or sinus-tarsi problem cannot be ruled out by a shoe guide.
Do I need a stability shoe?
Arch shape alone does not answer this. The review’s 80 percent pronated-foot series does not prove a stability-shoe benefit, and it also describes high-arched feet. The stability-shoe and supination discussions are construction/fit context, not a diagnostic prescription or guaranteed harm rule.
Why does it hurt most on uneven ground?
Uneven surfaces can change demands on the foot, and appear among the possible contributing factors discussed in the review. That observation does not prove a specific joint mechanism or that a higher torsional-rigidity number prevents symptoms. Describe the circumstances during an assessment rather than treating a stiffness figure as a clinical result.
What happens next on this page
No original stiffness, volume or wear-test records are documented. Any future first-hand report would require retained measurements, methods and fitting observations; it would not by itself establish a cuboid-treatment result. The volume method remains a proposal rather than a completed product rating. Until records exist, this page is a published-source comparison.
- Durall CJ. Examination and Treatment of Cuboid Syndrome: A Literature Review. Sports Health 2011;3(6):514–519. doi:10.1177/1941738111405965 (PMID 23016051, PMC3445231). Open access. Source of the prevalence figures (4% of 3,600 athletes with foot injuries, 17% of professional ballet dancers with foot or ankle injury, 6.7% after plantar-flexion/inversion ankle sprain), the 80%-pronated series, the 35%-of-joint-space labrum finding from a 41-foot cadaveric study, the risk-factor list including ill-fitting or poorly constructed orthoses or shoes, the 3–6 mm felt pad under the medial aspect of the cuboid and the lateral heel wedge, the manipulation-first recommendation, and the statements that no definitive diagnostic test exists and that evidence-based guidelines are lacking.
- Patterson SM. Cuboid syndrome: a review of the literature. Journal of Sports Science and Medicine 2006;5(4):597–606. (PMID 24357955, PMC3861761.) Source of the point that radiographic imaging is of little value and that the diagnosis rests on history and a collection of signs, and of the conservative-treatment picture in which manipulation is primary and padding and taping are adjuncts.
- RunRepeat laboratory measurements for the Brooks Ghost 18, Brooks Glycerin 23 and Brooks Adrenaline GTS 25 — torsional rigidity, longitudinal stiffness and forefoot flexibility, heel-counter stiffness, insole thickness, stack heights and midsole softness on the Asker C scale; read September 2026. Each figure is also cited on that shoe’s own page here. The ranges, medians and ranks this page quotes for the other shoes the lab has measured — torsional rigidity for 24, insole thickness for 35, midsole softness for 33 — are RunRepeat laboratory figures, read 28 September 2026.
- Brand-published specifications from Brooks, Skechers, Orthofeet and OOFOS — stated drop, widths, insole removability, extra depth and list price; read September 2026.
- Podiatrist Tested shoe spec database — the dated source dataset; some counts refer to specific subsets, not every current shoe or publication.
No shoe on this page has been tested by us. Nothing here is a diagnosis or a treatment recommendation, and the manual technique described is not something to attempt unsupervised; see our editorial policy.
- Best shoes for peroneal tendonitis — the tendon that runs under the cuboid, and the closest thing to a twin diagnosis.
- Best shoes for sinus tarsi syndrome — lateral foot pain a little further back, after the same ankle sprain.
- Best shoes for a tailor’s bunion — related forefoot symptoms and practical fit considerations.
- Best shoes for stress fractures — the differential that gets worse if you walk it off.
- Orthotic volume rating — practical device-fit questions; not a validated one-minute clearance test.
- Insoles and orthotics — what the trials actually found, including where they found nothing.
- Best shoes for overpronation and best shoes for supination — the two foot types this condition turns up in.
- Shoe spec database — every published figure on this site in one table, with who published each one.
- Best shoes for tarsal coalition — a different structural condition requiring individual assessment.
- Best shoes for midfoot arthritis — arthritis-related midfoot symptoms and the limits of footwear evidence.
Recently reviewed
Individual shoe pages state their evidence tier, published measurements and who should skip them.
Saucony Endorphin Speed 5
Spec AnalysisLight plated neutral trainer. Saucony publishes both stack heights and they match its 8 mm drop — not yet tested.
HOKA Mach 6
Spec AnalysisLower, firmer neutral HOKA. HOKA publishes a 5 mm drop and neither stack height — not yet tested.
ASICS Novablast 5
Spec AnalysisBouncy high-stack neutral. ASICS publishes an 8 mm drop and neither stack height — not yet tested.
Our funding and evidence policy
We earn affiliate commissions from qualifying purchases. Our policy is to assess published evidence and fit needs rather than rank products by commission rate. Current reviews are specification analyses; see our method for their limits.